ArticleTargeted oncology2024

Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study).

Ondřej Fiala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.